121 related articles for article (PubMed ID: 22777886)
1. Recent advances in targeted genome engineering in mammalian systems.
Sun N; Abil Z; Zhao H
Biotechnol J; 2012 Sep; 7(9):1074-87. PubMed ID: 22777886
[TBL] [Abstract][Full Text] [Related]
2. Mouse genome engineering using designer nucleases.
Hermann M; Cermak T; Voytas DF; Pelczar P
J Vis Exp; 2014 Apr; (86):. PubMed ID: 24747757
[TBL] [Abstract][Full Text] [Related]
3. Zinc Finger Nucleases: Tailor-made for Gene Therapy.
Chou ST; Leng Q; Mixson AJ
Drugs Future; 2012 Mar; 37(3):183-196. PubMed ID: 24155503
[TBL] [Abstract][Full Text] [Related]
4. Improving homology-directed repair by small molecule agents for genetic engineering in unconventional yeast?-Learning from the engineering of mammalian systems.
Lu M; Billerbeck S
Microb Biotechnol; 2024 Feb; 17(2):e14398. PubMed ID: 38376092
[TBL] [Abstract][Full Text] [Related]
5. megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering.
Boissel S; Jarjour J; Astrakhan A; Adey A; Gouble A; Duchateau P; Shendure J; Stoddard BL; Certo MT; Baker D; Scharenberg AM
Nucleic Acids Res; 2014 Feb; 42(4):2591-601. PubMed ID: 24285304
[TBL] [Abstract][Full Text] [Related]
6. Manipulating the mammalian genome by homologous recombination.
Vasquez KM; Marburger K; Intody Z; Wilson JH
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8403-10. PubMed ID: 11459982
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases.
Daboussi F; Zaslavskiy M; Poirot L; Loperfido M; Gouble A; Guyot V; Leduc S; Galetto R; Grizot S; Oficjalska D; Perez C; Delacôte F; Dupuy A; Chion-Sotinel I; Le Clerre D; Lebuhotel C; Danos O; Lemaire F; Oussedik K; Cédrone F; Epinat JC; Smith J; Yáñez-Muñoz RJ; Dickson G; Popplewell L; Koo T; VandenDriessche T; Chuah MK; Duclert A; Duchateau P; Pâques F
Nucleic Acids Res; 2012 Jul; 40(13):6367-79. PubMed ID: 22467209
[TBL] [Abstract][Full Text] [Related]
8. Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy.
Silva G; Poirot L; Galetto R; Smith J; Montoya G; Duchateau P; Pâques F
Curr Gene Ther; 2011 Feb; 11(1):11-27. PubMed ID: 21182466
[TBL] [Abstract][Full Text] [Related]
9. Biotechnology: Rewriting a genome.
Charpentier E; Doudna JA
Nature; 2013 Mar; 495(7439):50-1. PubMed ID: 23467164
[No Abstract] [Full Text] [Related]
10. Genome engineering on size reduction and complexity simplification: A review.
Chen XR; Cui YZ; Li BZ; Yuan YJ
J Adv Res; 2024 Jun; 60():159-171. PubMed ID: 37442424
[TBL] [Abstract][Full Text] [Related]
11. Advances in application of CRISPR-Cas13a system.
Zhang Y; Li S; Li R; Qiu X; Fan T; Wang B; Zhang B; Zhang L
Front Cell Infect Microbiol; 2024; 14():1291557. PubMed ID: 38524179
[TBL] [Abstract][Full Text] [Related]
12. The past and presence of gene targeting: from chemicals and DNA via proteins to RNA.
Geel TM; Ruiters MHJ; Cool RH; Halby L; Voshart DC; Andrade Ruiz L; Niezen-Koning KE; Arimondo PB; Rots MG
Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685979
[TBL] [Abstract][Full Text] [Related]
13. Advances in genome editing for improved animal breeding: A review.
Bhat SA; Malik AA; Ahmad SM; Shah RA; Ganai NA; Shafi SS; Shabir N
Vet World; 2017 Nov; 10(11):1361-1366. PubMed ID: 29263600
[TBL] [Abstract][Full Text] [Related]
14. Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.
Burnight ER; Gupta M; Wiley LA; Anfinson KR; Tran A; Triboulet R; Hoffmann JM; Klaahsen DL; Andorf JL; Jiao C; Sohn EH; Adur MK; Ross JW; Mullins RF; Daley GQ; Schlaeger TM; Stone EM; Tucker BA
Mol Ther; 2017 Sep; 25(9):1999-2013. PubMed ID: 28619647
[TBL] [Abstract][Full Text] [Related]
15. Fully Automated One-Step Synthesis of Single-Transcript TALEN Pairs Using a Biological Foundry.
Chao R; Liang J; Tasan I; Si T; Ju L; Zhao H
ACS Synth Biol; 2017 Apr; 6(4):678-685. PubMed ID: 28103009
[TBL] [Abstract][Full Text] [Related]
16. Development of Genetically Modified Chinese Hamster Ovary Host Cells for the Enhancement of Recombinant Tissue Plasminogen Activator Expression.
Rahimpour A; Ahani R; Najaei A; Adeli A; Barkhordari F; Mahboudi F
Malays J Med Sci; 2016 Mar; 23(2):6-13. PubMed ID: 27547109
[TBL] [Abstract][Full Text] [Related]
17. Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa.
Shinkuma S; Guo Z; Christiano AM
Proc Natl Acad Sci U S A; 2016 May; 113(20):5676-81. PubMed ID: 27143720
[TBL] [Abstract][Full Text] [Related]
18. Accelerated genome engineering through multiplexing.
Bao Z; Cobb RE; Zhao H
Wiley Interdiscip Rev Syst Biol Med; 2016; 8(1):5-21. PubMed ID: 26394307
[TBL] [Abstract][Full Text] [Related]
19. Direct observation of TALE protein dynamics reveals a two-state search mechanism.
Cuculis L; Abil Z; Zhao H; Schroeder CM
Nat Commun; 2015 Jun; 6():7277. PubMed ID: 26027871
[TBL] [Abstract][Full Text] [Related]
20. Obesity genetics in mouse and human: back and forth, and back again.
Yazdi FT; Clee SM; Meyre D
PeerJ; 2015; 3():e856. PubMed ID: 25825681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
